Novo Nordisk (NVO) announces the resolutions at its annual meeting. The company received authorization until the annual meeting in 2027 to repurchase its own shares of up to 10% of the share capital, subject to a holding limit of 10% of the share capital. Voters approved the re-election of Lars Rebien Sorensen as chair of the board. Shares of Novo Nordisk are up 2% to $37.09 in late morning trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk call volume above normal and directionally bullish
- Moderately bullish activity in Novo Nordisk with shares up 0.45%
- Eli Lilly Stock (LLY) Faces This Make-or-Break Test on April 10
- Novo Nordisk Advances DKK 15 Billion Share Buyback, Holds 0.6% in Treasury Shares
- Lexicon, Novo Nordisk announce initiation of LX9851 study